首页> 外文期刊>The journal of clinical psychiatry >Developing a Digital Medicine System in Psychiatry: Ingestion Detection Rate and Latency Period
【24h】

Developing a Digital Medicine System in Psychiatry: Ingestion Detection Rate and Latency Period

机译:开发精神病学数字医学系统:摄入检测率和潜伏期

获取原文
获取原文并翻译 | 示例
           

摘要

Background: A digital medicine system (DMS) has been developed to measure and report adherence to an atypical antipsychotic, aripiprazole, in psychiatric patients. The DMS consists of 3 components: ingestible sensor embedded in a medication tablet, wearable sensor, and secure mobile and cloud-based applications. An umbrella study protocol was designed to rapidly assess the technical performance and safety of the DMS in multiple substudies to guide the technology development.
机译:背景:已经开发出一种数字医学系统(DMS),用于测量和报告精神病患者对非典型抗精神病药物阿立哌唑的依从性。 DMS由3个组件组成:嵌入在药物平板电脑中的可摄入传感器,可穿戴传感器以及安全的移动和基于云的应用程序。设计了一个总体研究协议,可以在多个子研究中快速评估DMS的技术性能和安全性,以指导技术发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号